Sanyuan Biotechnology released its performance for the first three quarters, with a net profit attributable to the parent company of 67.3987 million yuan, a decrease of 16.80%

Sanyuan Biotechnology released its third-quarter report for 2025, with operating revenue of 476 million yuan for the first three quarters, a year-on-year decrease of 7.54%. The net profit attributable to the parent company was 67.3987 million yuan, a year-on-year decline of 16.80%; the net profit after deducting non-recurring gains and losses was 57.1343 million yuan, a year-on-year decrease of 28.11%. The basic earnings per share were 0.34 yuan